364 results
Page 9 of 19
8-K
EX-99.1
x7n861n6
6 Feb 14
Bristol-Myers Squibb Completes Previously Announced Sale of Global Diabetes Business to AstraZeneca
12:00am
8-K
EX-99.1
72tx547v66
24 Jan 14
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
EX-99.1
p8bdsh sbgr7zotpu7
19 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
uiobokl 07jtk
11 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
i6pwzw
23 Oct 13
Bristol-Myers Squibb Reports Third Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
ypai3l8juo8dcu h3p6
25 Jul 13
Bristol-Myers Squibb Reports Second Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
mp3p76gk
20 Jun 13
Bristol-Myers Squibb Names Dinesh C. Paliwal To Board of Directors
12:00am
8-K
EX-99.1
yxg77jxan0 4npopj
25 Apr 13
Bristol-Myers Squibb Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
eu9i3wavjo1se l7qx3
8 Apr 13
Departure of Directors or Certain Officers
12:00am
DEFA14A
kr9kvvxka1ipl7
8 Apr 13
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
44f9d o0x5rs4pw6bh8
24 Jan 13
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2012 Financial Results
12:00am
8-K
EX-99.1
i23 oabt5jtr96hve
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
1u1dhjsnxd5
3 Oct 12
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
12:00am
8-K
EX-99.1
dsi39rne m29o
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am